Rechtsmedizin

, Volume 22, Issue 5, pp 415–430 | Cite as

Succinylcholin in der forensischen Toxikologie

Verdachtsgewinnung und Beweissicherung bei Intoxikationen
CME Zertifizierte Fortbildung
First Online:

Zusammenfassung

Succinylcholin (SUX) ist ein depolarisierendes Muskelrelaxans, das eine potenziell letale Atemlähmung auslöst. Aufgrund dieser Wirkung besitzt SUX forensische Relevanz, da es z. B. bei Körperverletzungs- und Tötungsdelikten Anwendung finden kann. Das Erkennen einer SUX-Intoxikation ist aufgrund oft nur subtiler Hinweise stark erschwert. Nichtsdestotrotz ist insbesondere die frühzeitige Bestätigung von Verdachtsfällen in Kombination mit dem richtigen Handeln für die adäquate Beweissicherung und somit letztlich für die Aufklärung von forensischen Fällen von höchster Wichtigkeit. Da sich Intoxikationen meist in einem medizinischen Umfeld ereignen, sollen insbesondere Ärzte in den klinischen Disziplinen für diese Thematik sensibilisiert werden.

Schlüsselwörter

Succinylmonocholin Analytstabilität Blut Urin Gewebe 

Succinylcholine in forensic toxicology

Acquiring suspicion and evidence of intoxications

Abstract

Succinylcholine (SUX) is a depolarizing muscle relaxant which causes a potentially fatal respiratory paralysis. Exploiting this pharmacological profile, SUX can be misused, e.g. in cases of assault, (attempted) homicide and suicide, and therefore constitutes a forensically relevant substance. Due to often only subtle indications it is difficult to recognize an intoxication with SUX; however, an early identification and correct handling of suspicious cases is of utmost importance for securing potential evidence and thus solving forensic cases. As intoxications mostly happen in a medical environment, clinical practitioners in particular should be sensitized to the forensic relevance of SUX.

Keywords

Succinylmonocholine Drug stability Blood Urine Tissues 
This is a preview of subscription content, log in to check access.

Notes

Interessenkonflikt

Die korrespondierende Autorin gibt für sich und ihre Koautoren an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Durant NN, Katz RL (1982) Suxamethonium. Br J Anaesth 54:195–208PubMedCrossRefGoogle Scholar
  2. 2.
    Glick D (1941) Some additional observations on the specificity of cholinesterase. J Biol Chem 137:357–362Google Scholar
  3. 3.
    Roy JJ, Boismenu D, Gao H et al (2001) Measurement of succinylcholine concentration in human plasma by electrospray tandem mass spectrometry. Anal Biochem 290:238–244PubMedCrossRefGoogle Scholar
  4. 4.
    Kato M, Shiratori T, Yamamuro M et al (1999) Comparison between in vivo and in vitro pharmacokinetics of succinylcholine in humans. J Anesth 13:189–192PubMedCrossRefGoogle Scholar
  5. 5.
    Roy JJ, Donati F, Boismenu D, Varin F (2002) Concentration-effect relation of succinylcholine chloride during propofol anesthesia. Anesthesiology 97:1082–1092PubMedCrossRefGoogle Scholar
  6. 6.
    Lagerwerf AJ, Vanlinthout LE, Vree TB (1991) Rapid determination of succinylcholine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 570:390–395PubMedCrossRefGoogle Scholar
  7. 7.
    Pitts NI, Deftereos D, Mitchell G (2000) Determination of succinylcholine in plasma by high-pressure liquid chromatography with electrochemical detection. Br J Anaesth 85:592–598PubMedCrossRefGoogle Scholar
  8. 8.
    Lehmann H, Silk E (1953) Succinylmonocholine. Br Med J 1:767–768PubMedCrossRefGoogle Scholar
  9. 9.
    Foldes FF, Vandervort RS, Shanor SP (1955) The fate of succinylcholine in man. Anesthesiology 16:11–21PubMedCrossRefGoogle Scholar
  10. 10.
    Foldes FF (1953) Succinylmonocholine iodide: its enzymatic hydrolysis and neuromuscular activity. Proc Soc Exp Biol Med 83:187–189PubMedGoogle Scholar
  11. 11.
    Hunt R, Taveau R de M (1906) On the physiological action of certain cholin derivatives and new methods for detecting cholin. Br Med J 2:1788–1791CrossRefGoogle Scholar
  12. 12.
    Hunt R, Taveau R de M (1911) The effects of a number of derivatives of choline and analagous compounds on the blood pressure. Public Health and Marine Hospital Service, Hygienic Laboratory Bulletin 73Google Scholar
  13. 13.
    Bovet D, Bovet-Nitti F, Guarino S, Longo VG (1949) Pharmakodynamische Eigenschaften verschiedener Succinylcholin-Derivate mit curareartiger Wirkung. Aliphatische Trialkylethanolamin-Bicarbonsäureester. Rc. 1st. sup. Sanita 12:106–137Google Scholar
  14. 14.
    Phillips AP (1949) Synthetic curare substitutes from aliphatic dicarboxylic acid aminoethyl esters. J Am Chem Soc 71:3264CrossRefGoogle Scholar
  15. 15.
    Valdoni P (1949) Klinische Beobachtungen bei der Verwendung von curareartigen Muskelrelaxanzien. (Artikel auf Italienisch). Rc. 1st. sup. Sanita 12:255–262Google Scholar
  16. 16.
    Mazzoni P, Marghieri L (1950) Considerations on the use of some new synthetic curarizing agents. (Artikel auf Italienisch). G Ital Anestesiol 16:265–273PubMedGoogle Scholar
  17. 17.
    Brücke H, Ginzel KH, Klupp H et al (1951) Bis-Cholinester von Dicarbonsäuren als Muskelrelaxantien in der Narkose. Wien Klin Wochenschr 63:464–466PubMedGoogle Scholar
  18. 18.
    Rote Liste 2011 – Arzneimittelverzeichnis für Deutschland (einschließlich EU-Zulassungen und bestimmter Medizinprodukte). Rote Liste Service GmbH, Frankfurt/Main. ISBN:978-3-939192-50-3Google Scholar
  19. 19.
    Sparr HJ, Johr M (2002) Succinylcholine-Update. Anaesthesist 51:565–575PubMedCrossRefGoogle Scholar
  20. 20.
    Hofmockel R, Geldner G, Diefenbach C et al (2003) Application of muscle relaxants for rapid-sequence induction of anaesthesia. Anaesthesist 52:516–521PubMedGoogle Scholar
  21. 21.
    Loer SA, Tarnow J (1997) State of the art: „crush induction“. Anaesthesist 46:1015–1017PubMedGoogle Scholar
  22. 22.
    Morris J, Cook TM (2001) Rapid sequence induction: a national survey of practice. Anaesthesia 56:1090–1097PubMedCrossRefGoogle Scholar
  23. 23.
    Torda TA, Graham GG, Warwick NR, Donohue P (1997) Pharmacokinetics and pharmacodynamics of suxamethonium. Anaesth Intensive Care 25:272–278PubMedGoogle Scholar
  24. 24.
    Lehmann H, Ryan E (1956) The familial incidence of low pseudocholinesterase level. Lancet 271:124PubMedCrossRefGoogle Scholar
  25. 25.
    Kalow W, Staron N (1957) On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers. Can J Biochem Physiol 35:1305–1320PubMedCrossRefGoogle Scholar
  26. 26.
    Osmer C, Vogele C, Zickmann B, Hempelmann G (1996) Comparative use of muscle relaxants and their reversal in three European countries: a survey in France, Germany and Great Britain. Eur J Anaesthesiol 13:389–399PubMedCrossRefGoogle Scholar
  27. 27.
    Meakin GH (2001) Muscle relaxants in paediatric day case surgery. Eur J Anaesthesiol Suppl 23:47–52PubMedGoogle Scholar
  28. 28.
    Maltby JR (1975) Criminal poisoning with anaesthetic drugs: murder, manslaughter, or not guilty. Forensic Sci 6:91–108PubMedCrossRefGoogle Scholar
  29. 29.
    Somogyi G, Varga M, Prokai L (1989) Drug identification problems in two suicides with neuromuscular blocking agents. Forensic Sci Int 43:257–266PubMedCrossRefGoogle Scholar
  30. 30.
    Strock D, Kuczkowski KM, Greenberg M (2004) Accidental administration of succinylcholine for the treatment of hypotension in a labouring parturient. Can J Anaesth 51:853–854PubMedCrossRefGoogle Scholar
  31. 31.
    Sofianou A, Chatzieleftheriou A, Mavrommati P, Velmachou K (2006) Accidental epidural administration of succinylcholine. Anesth Analg 102:1139–1140PubMedCrossRefGoogle Scholar
  32. 32.
    Madea B, Dettmeyer R, Musshoff F (2008) Fall downstairs: accident, homicide or natural death? Forensic Sci Med Pathol 4:122–128PubMedCrossRefGoogle Scholar
  33. 33.
    Nordgren I, Baldwin K, Forney R Jr (1984) Succinylcholine – tissue distribution and elimination from plasma in the dog. Biochem Pharmacol 33:2519–2521PubMedCrossRefGoogle Scholar
  34. 34.
    Forney RB Jr, Carroll FT, Nordgren IK et al (1982) Extraction, identification and quantitation of succinylcholine in embalmed tissue. J Anal Toxicol 6:115–119PubMedGoogle Scholar
  35. 35.
    Baldwin KA, Forney R Jr (1988) The influence of storage temperature and chemical preservation on the stability of succinylcholine in canine tissue. J Forensic Sci 33:462–469PubMedGoogle Scholar
  36. 36.
    Dal Santo G (1968) Kinetics of distribution of radioactive labeled muscle relaxants. Anesthesiology 29:435–443CrossRefGoogle Scholar
  37. 37.
    Hoshi K, Hashimoto Y, Matsukawa S (1993) Pharmacokinetics of succinylcholine in man. Tohoku J Exp Med 170:245–250PubMedCrossRefGoogle Scholar
  38. 38.
    Kuepper U, Herbstreit F, Peters J et al (2011) Degradation and elimination of succinylcholine and succinylmonocholine and definition of their respective detection windows in blood and urine for forensic purposes. Int J Legal Med 126:259–269PubMedCrossRefGoogle Scholar
  39. 39.
    Foldes FF, Norton S (1954) The urinary excretion of succinyldicholine and succinylmonocholine in man. Br J Pharmacol Chemother 9:385–388PubMedGoogle Scholar
  40. 40.
    Kuepper U, Musshoff F, Madea B (2008) A fully validated isotope dilution HPLC-MS/MS method for the simultaneous determination of succinylcholine and succinylmonocholine in serum and urine samples. J Mass Spectrom 43:1344–1352PubMedCrossRefGoogle Scholar
  41. 41.
    Ballard KD, Vickery WE, Nguyen LT et al (2006) An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using lc-ms/ms on a tandem quadrupole/time-of-flight instrument. J Am Soc Mass Spectrom 17:1456–1468PubMedCrossRefGoogle Scholar
  42. 42.
    Kuepper U, Musshoff F, Madea B (2011) Applicability of succinylmonocholine as a marker for succinylcholine administration. Comparative analysis of samples from a fatal succinylcholine-intoxication versus postmortem control specimens. Forensic Sci Int 207:84–90PubMedCrossRefGoogle Scholar
  43. 43.
    Kuepper U, Musshoff F, Hilger RA et al (2011) Pharmacokinetic properties of succinylmonocholine in surgical patients. J Anal Toxicol 35:302–311PubMedCrossRefGoogle Scholar
  44. 44.
    Roy JJ, Varin F (2004) Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic-pharmacodynamic relationship. Br J Anaesth 93:241–248PubMedCrossRefGoogle Scholar
  45. 45.
    Baldwin KA, Forney R Jr (1988) Correlation of plasma concentration and effects of succinylcholine in dogs. J Forensic Sci 33:470–479PubMedGoogle Scholar
  46. 46.
    Tsutsumi H, Nishikawa M, Katagi M, Tsuchihashi H (2003) Adsorption and stability of suxamethonium and its major hydrolysis product succinylmonocholine using liquid chromatography-electrospray ionization mass spectrometry. J Health Sci 49:285–291CrossRefGoogle Scholar
  47. 47.
    Foldes FF, McNall PG, Birch JH (1954) The neuromuscular activity of succinylmonocholine iodide in anaesthetized man. Br Med J 1:967–968PubMedCrossRefGoogle Scholar
  48. 48.
    Stevens HM, Moffat AC (1974) A rapid screening procedure for quaternary ammonium compounds in fluids and tissues with special reference to suxamethonium (succinylcholine). J Forensic Sci Soc 14:141–148PubMedCrossRefGoogle Scholar
  49. 49.
    LeBeau M, Quenzer C (2003) Succinylmonocholine identified in negative control tissues. J Anal Toxicol 27:600–601PubMedGoogle Scholar
  50. 50.
    Kuepper U, Musshoff F, Madea B (2008) Succinylmonocholine analytics as an example for selectivity problems in high-performance liquid chromatography/tandem mass spectrometry, and resulting implications for analytical toxicology. Rapid Commun Mass Spectrom 22:1965–1970PubMedCrossRefGoogle Scholar
  51. 51.
    Ikarashi Y, Hada T, Way EL, Maruyama Y (1990) Determination of succinylcholine hydrolytic enzyme activity in human plasma. J Chromatogr 533:23–33PubMedCrossRefGoogle Scholar
  52. 52.
    Meyer E, Lambert WE, Leenheer A de (1997) Succinic acid is not a suitable indicator of suxamethonium exposure in forensic blood samples. J Anal Toxicol 21:170–171PubMedGoogle Scholar
  53. 53.
    Kerskes CH, Lusthof KJ, Zweipfenning PG, Franke JP (2002) The detection and identification of quaternary nitrogen muscle relaxants in biological fluids and tissues by ion-trap LC-ESI-MS. J Anal Toxicol 26:29–34PubMedGoogle Scholar
  54. 54.
    Massoulie J, Pezzementi L, Bon S et al (1993) Molecular and cellular biology of cholinesterases. Prog Neurobiol 41:31–91PubMedCrossRefGoogle Scholar
  55. 55.
    Moriya F, Hashimoto Y (1999) Comparative studies on tissue distributions of organophosphorus, carbamate and organochlorine pesticides in decedents intoxicated with these chemicals. J Forensic Sci 44:1131–1135PubMedGoogle Scholar
  56. 56.
    Appleyard ME, McDonald B, Benjamin L (1991) Presence of a soluble form of acetylcholinesterase in human ocular fluids. Br J Ophthalmol 75:276–279PubMedCrossRefGoogle Scholar
  57. 57.
    Malthe-Sorenssen D, Odden E, Blanch J et al (1986) Determination of succinyldicholine in different tissue samples from guinea pigs after injection of a single intravenous dose. Forensic Sci Int 32:171–178PubMedCrossRefGoogle Scholar
  58. 58.
    Goedde HW, Held KR, Altland K (1968) Hydrolysis of succinyldicholine and succinylmonocholine in human serum. Mol Pharmacol 4:274–287PubMedGoogle Scholar
  59. 59.
    Kuepper U (2010) Succinylcholin und Succinylmonocholin – Methodik und Qualitätssicherung der Analyse instabiler Zielsubstanzen im Rahmen der forensisch-toxikologischen Fallarbeit sowie wissenschaftlicher Studien. Dissertation an der Rheinischen Friedrich-Wilhelms-Universität zu Bonn. http://hss.ulb.uni-bonn.de/2010/2386/2386.htmGoogle Scholar
  60. 60.
    Skopp G, von Meyer L (2004) Anhang D – Empfehlungen zur Asservierung von Obduktionsmaterial für forensisch-toxikologische Untersuchungen und spezielle Aspekte der Postmortem-Analytik (letzter Teil in Bearbeitung). Toxichem + Krimtech 71:101–111Google Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Institut für Rechtsmedizin – ToxikologieUniversitätsklinikum EssenEssenDeutschland
  2. 2.Institut für RechtsmedizinUniversitätsklinikum BonnBonnDeutschland

Personalised recommendations